The Eighth Annual International Employment Survey - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Eighth Annual International Employment Survey


Pharmaceutical Technology



Figure 4: Salary according to job function.
Salary according to job function. The five highest paying jobs were in consulting, production management, computer information services and technology, drug delivery, and biopharmaceutics (see Figure 4). Most fields showed an increase in their mean base annual salaries compared with values reported in last year's survey.




Salary according to location. On average, employees in Northeastern and Western states earned the highest salaries (see Figure 5). Salaries in these regions were nearly 45% higher than those in Puerto Rico, which reported in the lowest values.

Benefits. The most common benefits include general health insurance, dental or supplemental health insurance, life insurance, and employer-provided 401k match contributions (see Table III). Other benefits that were reported but not listed in the questionnaire include flexible spending accounts, vision care, and health-club memberships.


Figure 5: Mean annual base salary
On average, employees are granted 10 paid public holidays and 18.7 paid vacation days, though most took only 15 days of vacation and admitted to doing some work (e.g., checking e-mail, returning calls) for at least 4 of these days.

Attitudes toward current employment


Table III: Percent age of respondents receiving the following employer-provided benefits.
Survey participants indicated how strongly they agreed or disagreed with the following statements:
  • I believe my work is fully valued by my employer.
  • I believe my present job is secure.
  • In my present job, I use my skills and training to the fullest extent.
  • Given the opportunity, I would leave my present job.

Most respondents continue to feel secure in their jobs, agree that their employer values their work, and believe that they use their skills to the fullest extent in their present jobs (see Table IV). US-only results show that 52% of workers either agreed or strongly agreed that they would leave their present job if given the opportunity, a 6% increase from last year.


Table IV: Opinions toward current employment.
Income, geographic location, and the opportunity for professional advancement were the three most important factors that would be taken into consideration for making this change. About 30% of respondents considered job security, intellectual challenge, and job environment to be top-level decision factors in considering a job change. The least important factors for making a job change were scientific opportunities, vacation entitlement, and health and safety.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here